Genomic data can provide more targeted insights into chronic disease management than those generated from traditional ethnic or racial labels like Hispanic or Black, a study published in Cell...
An analysis of genetic data indicates that leaders should prioritize clinical trials of two proteins – IFNAR2 and ACE2 – to better treat COVID-19 in its early stages.
In a study published...
A new blood test may reveal the biological basis of mood disorders and offer precision medicine approaches to treatment, according to a study published in Molecular Psychiatry.
Mood disorders affect...
In a study of end-stage heart failure patients, researchers at the University of Alabama at Birmingham (UAB) found that race and socioeconomic factors may contribute to differences heart failure...
A first-of-its-kind genomic data analysis revealed 13 new genetic variants associated with Alzheimer’s disease, according to a study conducted by researchers from Massachusetts General Hospital...
Analyzing the genomic data of thousands of COVID-19 samples showed that surges in cases are driven by the appearance of new variants, according to a study published in Scientific...
Using deep learning and genomic data, researchers from Beaumont Health have discovered a simple blood test that may help predict Alzheimer’s disease in patients.
In a study published in PLOS...
Machine learning approaches could help detect mutational signatures in patients with cancer, revealing the genetic effects of the underlying contributors to the disease, a study published in eLife...
Cleveland Clinic and IBM have announced a ten-year partnership to launch the Discovery Accelerator, a center aimed at using artificial intelligence, high performance on the hybrid cloud, and quantum...
Brigham Young University’s (BYU) Center for Family History and Genealogy and the University of Washington have partnered to prevent hereditary cancer using genetic data.
The Connect My Variant...
Limited diversity in genomic datasets may affect therapy selection and cancer outcomes for black patients, a study published in npj Precision Oncology revealed.
Researchers noted that clinicians use...
Henry Ford Cancer Institute is launching a new, community-based initiative to significantly improve minority representation in cancer genetics research and clinical trials.
Supported by a $750,000...
The emergence of next-generation sequencing technology has led to widespread genomic testing and the availability of genomic data, providing a way for clinicians and patients to better understand...
Genomic data has emerged as a comprehensive resource that can help researchers and providers better understand the underlying mechanisms of disease, leading to improved population health.
During the...
Personalization is something most people have come to appreciate – if not expect – in everyday, consumer-driven experiences.
From recommended movies and shows based on what you’ve watched, to playlists tailored to your...
NIH has launched the next version of the Accelerating Medicines Partnership Alzheimer’s disease program (AMP AD 2.0), an effort to enable precision medicine treatments for Alzheimer’s.
AMP...
Using a new data analytics approach, researchers could enhance cancer drug response predictions by accounting for overlooked variation across and within cancer types, a study published in PLOS...
Examining diverse genetic data helped researchers discover a gene variant associated with childhood asthma development, demonstrating the importance of including diverse populations in research,...
An innovative approach helped researchers analyze the role of protein-protein interactions (PPIs) in cases of hypertrophic cardiomyopathy (HCM), a discovery that could advance precision medicine...
Genetic data can help improve prostate cancer risk prediction in diverse racial and ethnic groups, leading to more targeted, personalized screenings, according to a study published in Nature...
